Mass Tort brief
Judges Reshape the Scientific Standards of Mass Injury Claims
Twin rulings on talc and acetaminophen put the legal rules for expert medical testimony at the center of multi-billion-dollar liabilities.
Mass Tort
By narrowing judges' power to screen out expert science, the court handed 500 plaintiffs their leverage back — Kenvue now faces juries, and pressure toward a settlement in the billions.
BackgroundMass tort litigation relies heavily on expert scientific testimony to prove that a product directly caused a specific injury. Under the Daubert standard, trial judges act as gatekeepers to ensure only scientifically rigorous, reliable methods reach a jury.
- The appellate panel ruled that the district court overstepped its gatekeeping authority by tossing three of the plaintiffs' causation experts, lowering the bar for scientific evidence.
- The decision does not rule on the merits of the scientific theory but allows the lawsuits to proceed toward trial, exposing major retailers to massive potential liabilities.
- Defense attorneys warned the ruling weakens scientific standards, opening the door for speculative claims to influence juries and driving up future settlement values across other mass torts.
Mass Tort
By demanding proof before trials begin, the judge has pushed 67,000 talc claims to the brink of collapse — handing J&J massive leverage to force a cheap settlement.
BackgroundJohnson & Johnson faces mass tort litigation alleging its baby powder contains asbestos that causes ovarian cancer. The company has repeatedly attempted to settle the claims through structured bankruptcies, while plaintiffs push for jury trials.
- Judge Rukhsanah Singh expressed deep skepticism that plaintiffs can present reliable scientific testimony, raising the prospect of a massive dismissal before any trials begin.
- Two major gynecological oncology experts withdrew their testimony after depositions revealed major inconsistencies, stripping the plaintiffs of their primary scientific backing in court.
- Plaintiffs have until November 19 to present robust scientific evidence, forcing law firms to scramble for replacement experts or face an unprecedented collapse of their cases.
Unlock the full brief
Sign in to read every signal, takeaway, and source. Free account — Apple, Google, or email.